Make us your home page

FDA approves new tuberculosis drug

FDA okays drug for tuberculosis

The Food and Drug Administration on Monday approved a Johnson & Johnson tuberculosis drug that is the first new medicine to fight the deadly infection in more than four decades. The agency approved the pill Sirturo for use with older drugs to fight a hard-to-treat strain of TB that has not responded to other medications. However, the agency cautioned that the drug carries risks of potentially deadly heart problems and should be prescribed carefully by doctors. Although rare in the United States, drug-resistant TB is a growing problem elsewhere in the world, especially in poorer countries. About 12 million people worldwide had tuberculosis in 2011, according to Johnson & Johnson, and about 630,000 had drug-resistant TB.

'Fiscal cliff' lives in banishment

A dozen dirty words and phrases have landed on the 38th annual List of Words to be Banished from the Queen's English for Misuse, Overuse and General Uselessness. The nonbinding, tongue-in-cheek decree released Monday by Michigan's Lake Superior State University is based on nominations submitted from the United States, Canada and beyond. Spokesman Tom Pink said that in nearly four decades, the Sault Ste. Marie school has "banished" around 900 words or phrases. This year's list:

• Fiscal cliff.

• Kick the can down the road.

• Double down.

• Job creators/creation.

• Passion/passionate.

• YOLO (you only live once).

• Spoiler alert.

• Bucket list.

• Trending.

• Superfood.

• Boneless wings.

• Guru.

Times wires

By the numbers

315.1M Estimated population of the United States on New Year's Day, a 0.73 percent increase from last year's estimate.

7.3 Percent increase in the population projected for this decade, the lowest level since the 7.25 percent recorded between 1930 and 1940, according to data compiled by Bloomberg News.

FDA approves new tuberculosis drug 12/31/12 [Last modified: Monday, December 31, 2012 7:05pm]
Photo reprints | Article reprints

Copyright: For copyright information, please check with the distributor of this item, Associated Press.

Join the discussion: Click to view comments, add yours